These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6488522)

  • 1. Measurement of gliclazide in plasma by radial compression reversed-phase liquid chromatography.
    Charles BG; Ravenscroft PJ
    Clin Chem; 1984 Nov; 30(11):1789-91. PubMed ID: 6488522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversed-phase high-performance liquid chromatographic determination of gliclazide in human plasma.
    Kimura M; Kobayashi K; Hata M; Matsuoka A; Kaneko S; Kitamura H; Kimura Y
    Chem Pharm Bull (Tokyo); 1980 Jan; 28(1):344-6. PubMed ID: 7363377
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of gliclazide in human serum by high-performance liquid chromatography using an anion-exchange resin.
    Kimura M; Kobayashi K; Hata M; Matsuoka A; Kitamura H; Kimura Y
    J Chromatogr; 1980 Oct; 183(4):467-73. PubMed ID: 7430298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gas-liquid chromatographic method for determination of plasma gliclazide (author's transl)].
    Kimura M; Kobayashi K; Takashima S; Ino T; Hata M; Matsuoka A; Kaneko S; Kimura Y
    Rinsho Byori; 1980 Jan; 28(1):63-6. PubMed ID: 7373877
    [No Abstract]   [Full Text] [Related]  

  • 5. High-performance liquid chromatographic determination of gliclazide in human plasma.
    Poirier JM; Perez M; Cheymol G
    J Chromatogr; 1987 Oct; 421(1):223-6. PubMed ID: 3429572
    [No Abstract]   [Full Text] [Related]  

  • 6. [High-performance liquid chromatographic determination of gliclazide (oral hypoglycemic agent) in serum--trial of sensitive fluorometric determination].
    Igaki A; Kobayashi K; Kimura M; Sakoguchi T; Hashimoto M; Matsuoka A
    Rinsho Byori; 1986 Feb; 34(2):201-5. PubMed ID: 3702090
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of serum gliclazide (hypoglycemic drug) by high performance liquid chromatography, using diaion CDR-10 column].
    Kobayashi K; Kimura M; Sakoguchi T; Kitani Y; Takashima S; Mimura K; Matsuoka A; Kimura Y
    Rinsho Byori; 1981 Sep; 29(9):895-901. PubMed ID: 7328815
    [No Abstract]   [Full Text] [Related]  

  • 8. Gas chromatographic determination of the hypoglycaemic agent gliclazide in plasma.
    Maeda T; Yamaguchi T; Hashimoto M
    J Chromatogr; 1981 May; 223(2):357-63. PubMed ID: 7251790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of capillary electrophoresis with HPLC for diagnosis of factitious hypoglycemia.
    Paroni R; Comuzzi B; Arcelloni C; Brocco S; de Kreutzenberg S; Tiengo A; Ciucci A; Beck-Peccoz P; Genovese S
    Clin Chem; 2000 Nov; 46(11):1773-80. PubMed ID: 11067812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized procedure for the assay and identification of hypoglycemic sulfonylureas in human plasma.
    Sener A; Akkan AG; Malaisse WJ
    Acta Diabetol; 1995 Mar; 32(1):64-8. PubMed ID: 7612921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A screening test for detecting sulfonylureas in plasma.
    Shenfield GM; Boutagy JS; Webb C
    Ther Drug Monit; 1990 Jul; 12(4):393-7. PubMed ID: 2118693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of blood proteins on biomedical analysis. IX. Protective effects of human serum proteins on anion-induced degradation of gliclazide.
    Kobayashi K; Igaki A; Kimura M; Sakoguchi T; Shimosawa M; Matsuoka A
    Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2957-62. PubMed ID: 3769097
    [No Abstract]   [Full Text] [Related]  

  • 13. High-performance liquid chromatography with electrochemical detection for analysis of gliclazide in plasma.
    Kuo CY; Wu SM
    J Chromatogr A; 2005 Sep; 1088(1-2):131-5. PubMed ID: 16130741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of gliclazide by semi-micro high-performance liquid chromatography: application to a bioequivalence study of two formulations in healthy subjects.
    Park JY; Kim KA; Kim SL; Park PW
    J Pharm Biomed Anal; 2004 Jun; 35(4):943-9. PubMed ID: 15193740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of blood proteins on biomedical analysis. III. Pharmacokinetics and protein binding of gliclazide.
    Kobayashi K; Kimura M; Sakoguchi T; Kitani Y; Hata M; Matsuoka A
    J Pharmacobiodyn; 1981 Jun; 4(6):436-42. PubMed ID: 7288560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple and sensitive HPLC method for determination of gliclazide in human serum.
    Rouini MR; Mohajer A; Tahami MH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Mar; 785(2):383-6. PubMed ID: 12554153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of monolithic column in quantification of gliclazide in human plasma by liquid chromatography.
    Foroutan SM; Zarghi A; Shafaati A; Khoddam A
    J Pharm Biomed Anal; 2006 Oct; 42(4):513-6. PubMed ID: 16797910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of gliclazide in serum by high-performance liquid chromatography using solid-phase extraction.
    Noguchi H; Tomita N; Naruto S; Nakano S
    J Chromatogr; 1992 Dec; 583(2):266-9. PubMed ID: 1478992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of oral antidiabetic drugs in human plasma using microextraction by packed sorbent and high-performance liquid chromatography.
    Viana IM; Lima Pde P; Soares CD; Fernandes C
    J Pharm Biomed Anal; 2014 Aug; 96():241-8. PubMed ID: 24780925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of a new hypoglycemic drug, gliclazide, in human serum by radioimmunoassay.
    Suzuki H; Miki M; Sekine Y; Kagemoto A; Negoro T; Maeda T; Hashimoto M
    J Pharmacobiodyn; 1981 Mar; 4(3):217-25. PubMed ID: 7252771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.